Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Keller Group CFO snaps up shares

(Sharecast News) - Keller Group revealed on Monday that chief financial officer David Burke had acquired 15,012 ordinary shares in the FTSE 250-listed geotechnical engineering company. Burke, who took over as CFO in 2020, purchased the shares on Friday at an average price of 657.0p, for a total value of £98,628.84.

Michael Speakman, Keller's chief executive, also snapped up some shares, raisins his stake by 3,000 at 665.0p per share, for a total transaction value of £19,950.

As of 1625 GMT, Keller shares were up 0.15% at 667.0p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Litigation Capital Management Limited (di) (LIT) Director name: Moulds,Jonathan Amount purchased: 1,675,000 @ 71.35p Value: £1,195,112.54

Atlantic Lithium Limited Npv (di) (ALL) Director name: Herbert,Neil Lindsey Amount purchased: 1,802,685 @ 27.58p Value: £497,180.50

(MCI) Director name: Yeoman ,Marcus Amount purchased: 35,816 @ 349.00p Value: £124,997.84

Litigation Capital Management Limited (di) (LIT) Director name: Moloney,Patrick Amount purchased: 157,092 @ 71.00p Value: £111,535.32

(MCI) Director name: Yeoman ,Marcus Amount purchased: 25,062 @ 399.00p Value: £99,997.38

Keller Group (KLR) Director name: Burke,David Amount purchased: 15,012 @ 657.00p Value: £98,628.84

(MCI) Director name: Yeoman ,Marcus Amount purchased: 25,000 @ 295.00p Value: £73,750.00

Atlantic Lithium Limited Npv (di) (ALL) Director name: Harsas ,Amanda Amount purchased: 228,500 @ $0.49 Value: $59,081.30

Atlantic Lithium Limited Npv (di) (ALL) Director name: Harsas ,Amanda Amount purchased: 200,000 @ 26.75p Value: £53,500.00

(MCI) Director name: Yeoman ,Marcus Amount purchased: 10,030 @ 498.50p Value: £49,999.55

Gsk (GSK) Director name: Symonds,Jonathan Amount purchased: 2,100 @ 1,398.84p Value: £29,375.64

Atlantic Lithium Limited Npv (di) (ALL) Director name: Harsas ,Amanda Amount purchased: 100,000 @ 27.00p Value: £27,000.00

Superdry (SDRY) Director name: Wills,Shaun Amount purchased: 126 @ 19,400.00p Value: £24,444.00

Keller Group (KLR) Director name: Speakman,Michael Amount purchased: 3,000 @ 665.00p Value: £19,950.00

Atlantic Lithium Limited Npv (di) (ALL) Director name: Herbert,Neil Lindsey Amount purchased: 80,492 @ $0.46 Value: $19,384.89

Atlantic Lithium Limited Npv (di) (ALL) Director name: Harsas ,Amanda Amount purchased: 43,000 @ $0.47 Value: $10,767.64

Gran Tierra Energy Inc. (cdi) (GTE) Director name: Guidry,Gary Amount purchased: 4,967 @ $0.73 Value: $2,989.95

Centaur Media (CAU) Director name: Mukerji,Swagatam Amount purchased: 445 @ 50.80p Value: £226.06

Howden Joinery Group (HWDN) Director name: Livingston,Andrew Amount purchased: 22 @ 680.20p Value: £149.64

Victrex Plc (VCT) Director name: Court ,Martin Amount purchased: 9 @ 1,632.00p Value: £146.88

Tesco (TSCO) Director name: Murphy,Ken Amount purchased: 55 @ 251.38p Value: £138.26

Thor Energy (THR) Director name: McGeough,Mark Amount purchased: 45,000 @ $0.01 Value: $119.09

Top Director Sells

Share this article

Related Sharecast Articles

Director dealings: Blue Coast raises stake in Everyman Media
(Sharecast News) - Everyman Media revealed on Thursday that Blue Coast had acquired 50,000 ordinary shares in the AIM-listed cinema group.
Director dealings: Angus Energy CEO ups stake
(Sharecast News) - Angus Energy revealed on Wednesday that chief executive Richard Herbert had acquired 5.0m ordinary shares in the AIM-listed onshore oil and gas development firm.
Director dealings: Abrdn CEO makes share sale
(Sharecast News) - Abrdn revealed on Monday that chief executive Stephen Bird had disposed of 29,942 ordinary shares in the FTSE 250-listed global investment company.
Director dealings: Redx Pharma CEO ups stake
(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.